insights_auto
Why is 600535 up 2.22%?
Dive Deeperchevron_right
600535:SHA
Tasly Pharmaceutical Group Co Ltd
CNÂ¥14.28
arrow_upward
+2.22%(+0.31) 1D
Oct 14, 3:00:01 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 600535...
Open
CNÂ¥14.00
High
CNÂ¥14.31
Low
CNÂ¥13.93
Mkt. cap
21.24B
Avg. vol.
11.81M
Volume
15.47M
Dividend
2.38%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
May 29, 2026
P/E ratio
17.44
52-wk high
CNÂ¥16.24
52-wk low
CNÂ¥12.90
EPS
CNÂ¥0.82
Shares outstanding
1.51B
No. of employees
11K
Open
CNÂ¥14.00
High
CNÂ¥14.31
Low
CNÂ¥13.93
Mkt. cap
21.24B
Avg. vol.
11.81M
Volume
15.47M
Dividend
2.38%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
May 29, 2026
P/E ratio
17.44
52-wk high
CNÂ¥16.24
52-wk low
CNÂ¥12.90
EPS
CNÂ¥0.82
Shares outstanding
1.51B
No. of employees
11K
Related stocks
News stories
From web sources and news partners
Seeking Alpha
·
11 minutes ago
Dow Jones Industrial Average Monitor Update - A Look At 30 U.S. Large-Caps
TradingView
·
31 minutes ago
Key facts: NASDAQ:BMBL to Go Private $1.3B; Greenoaks, Users -16%
Stocktwits
·
1 hour ago
UNH Stock Outpaces S&P 500 In 2026, Eyes Best Year Since Pandemic — CFO Says Wall Street May Be Missing 2027 Upside
Investor's Business Daily
·
4 hours ago
Tech Futures Rise: Meta, AMD Lead 5 Buys; ASML, CPI Inflation Due
Profile
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
About Tasly Pharmaceutical Group Co Ltd